Bacterial keratitis is an important cause of visual morbidity worldwide,(1)
Contact lens wear remains the most common risk factor for bacterial kerati
tis in most developed countries.' Interestingly, another form of refractive
correction, in the form of incisional and laser surgery, has emerged as a
cause of bacterial keratitis. Incisional refractive surgery has been report
ed to have a complication rate for incidence of bacterial keratitis of 0.25
to 0.70%, with reoperation or enhancement after the primary procedure bein
g a risk factor for infection.(3) Because of the large epithelial defect th
at follows surface excimer laser treatment, one would expect a higher incid
ence of infection as compared with incisional techniques. However, few data
are available on the incidence of infectious keratitis after photorefracti
ve keratectomy (PRK). Amayen and associates(4) reported 2 cases of bacteria
l keratitis after PRK. The authors did not report the patient population si
ze that included these patients and an estimate of the incidence of bacteri
al keratitis. Al-Rajhi and associates(5) reported three cases of bacterial
keratitis in a series of 258 patients undergoing phototherapeutic keratecto
my. This yielded an incidence of 1.2%. Automated lamellar keratoplasty and
laser in situ keratomileusis (LASIK) have been associated with postoperativ
e bacterial keratitis.(6,7) One of these cases was an unfortunate patient w
ith bilateral bacterial keratitis after bilateral simultaneous LASIK.(7)
Although this is a rare complication, it is an additional reason why we rec
ommend against bilateral simultaneous LASIK. Although the clinical impact o
f bacterial keratitis is not controversial, a number of aspects regarding t
he diagnosis and treatment of bacterial keratitis have become fairly contro
versial in the last few years, igniting some furious debates. The purpose o
f this chapter is to review the recent literature and to discuss two contro
versial areas regarding bacterial keratitis: the use of cultures in the dia
gnosis and determination of treatment of corneal ulcers, and the use of flu
oroquinolones in the treatment of bacterial keratitis.